
IceCure Medical, an Israeli company developing a minimally invasive medical device for treating tumors, recently announced that it will start offering its technology, called cryoablation, in Israel in upcoming weeks.
The company’s device is an ultrasound imaging-guided probe that injects liquid nitrogen into a tumor and does not require hospitalization, leaves minimal to no scarring, and has a short recovery time. Destroyed tumor cells are then reabsorbed in the body over time.
The treatment, which is approved in the US and the European Union, will be available in Israel to women suffering from fibroadenomas, benign breast tumors usually found in women under 30, and for patients with malignant kidney tumors.
Article excerpts from calcalisttech.com
As one of the global leaders in the field of invasive endovascular procedures, Dr. Alexander Belenky, head of the Interventional Radiology Unit at Israel's Rabin Medical Center, recently presided over a conference for more than 100 radiologists from over 70 vascular centers in Russia.
Menashe Kadishman has donated 18 of his magnificent works of art to the opening of the Institute of Pulmonary Medicine at Rabin Medical Center.
Tel Aviv University study has determined that natural, spontaneous deliveries and induced deliveries following the rupture of the amniotic sac in the mother share similar neonatal outcomes, contradicting common wisdom.